Nonalcoholic Steatohepatitis Terminated Phase Trials for Sitagliptin (DB01261)

IndicationStatusPhase
DBCOND0029353 (Nonalcoholic Steatohepatitis)TerminatedNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01260246Sitagliptin for the Treatment of Non-alcoholic Steatohepatitis in Patients With Type 2 DiabetesTreatment